Trial Profile
Drug interaction study of dalcetrapib and ezetimibe in male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Mar 2011
Price :
$35
*
At a glance
- Drugs Dalcetrapib (Primary) ; Ezetimibe (Primary)
- Indications Cardiovascular disorders; Lipid metabolism disorders
- Focus Pharmacokinetics
- Sponsors Roche
- 24 Mar 2011 New trial record